Pharmacological Mechanism of the Non-hallucinogenic 5-HT2A Agonist Ariadne and Analogs
Zenodo (CERN European Organization for Nuclear Research) 2023 DOI: 10.5281/zenodo.16912423 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Conference presentation Peer reviewed |
|---|---|
| Keywords | Mechanism biology Mechanism of action Agonist-antagonist Biological activity Pharmacology |
| Key points | Ariadne and its analogs act as non-hallucinogenic 5-HT2A agonists, offering a distinct pharmacological mechanism from hallucinogenic psychedelics. |
Abstract
Michael Cunningham - Pharmacological Mechanism of the Non-hallucinogenic 5-HT2A Agonist Ariadne and Analogs (psychedelic molecules, 4th-5th September 2023, Prague, Czech Republic)